BASF - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.0
| Stock Code | BASF | Market Cap | 15,090 Cr. | Current Price | 3,488 ₹ | High / Low | 5,400 ₹ |
| Stock P/E | 36.2 | Book Value | 919 ₹ | Dividend Yield | 0.57 % | ROCE | 14.7 % |
| ROE | 10.9 % | Face Value | 10.0 ₹ | DMA 50 | 3,661 ₹ | DMA 200 | 3,992 ₹ |
| Chg in FII Hold | 1.21 % | Chg in DII Hold | -0.13 % | PAT Qtr | 63.6 Cr. | PAT Prev Qtr | 105 Cr. |
| RSI | 39.2 | MACD | 14.4 | Volume | 29,595 | Avg Vol 1Wk | 70,168 |
| Low price | 2,907 ₹ | High price | 5,400 ₹ | PEG Ratio | 12.4 | Debt to equity | 0.03 |
| 52w Index | 23.3 % | Qtr Profit Var | 93.2 % | EPS | 96.3 ₹ | Industry PE | 29.2 |
📊 Financial Overview: BASF demonstrates moderate return metrics with ROCE at 14.7% and ROE at 10.9%. Debt-to-equity at 0.03 reflects a nearly debt-free balance sheet, ensuring financial stability. However, quarterly profit fell from ₹105 Cr. to ₹63.6 Cr., highlighting earnings volatility. Despite this, the company maintains operational resilience supported by global scale.
💹 Valuation Indicators: The stock trades at a P/E of 36.2 compared to the industry average of 29.2, suggesting overvaluation. With a book value of ₹919, the P/B ratio is ~3.8, which is reasonable. PEG ratio of 12.4 indicates growth is insufficient to justify the premium valuation. Intrinsic value appears lower than the current market price of ₹3,488.
🏢 Business Model & Competitive Advantage: BASF operates in the specialty chemicals sector, leveraging global expertise, diversified product lines, and strong R&D. Its competitive advantage lies in innovation and scale, though profitability volatility and cyclical demand affect overall health.
📈 Entry Zone & Long-Term Guidance: Current price ₹3,488 is above intrinsic comfort levels. A better entry zone would be closer to ₹3,000–₹3,200, aligning with technical support. Long-term holding is advisable only if earnings stabilize and valuation moderates.
Positive
- ✅ Debt-to-equity at 0.03 ensures financial stability.
- ✅ Strong global presence and diversified product portfolio.
- ✅ FII holding increased by 1.21%, showing foreign investor confidence.
Limitation
- ⚠️ P/E (36.2) above industry average (29.2).
- ⚠️ PEG ratio (12.4) signals overvaluation relative to growth.
- ⚠️ Dividend yield (0.57%) remains modest.
Company Negative News
- 📉 Quarterly profit declined from ₹105 Cr. to ₹63.6 Cr.
- 📉 DII holding decreased by -0.13%, showing reduced domestic support.
Company Positive News
- 📈 RSI at 39.2 indicates oversold levels, suggesting potential rebound.
- 📈 MACD at 14.4 highlights short-term bullish momentum.
Industry
- 🏭 Specialty chemicals industry P/E at 29.2, lower than BASF’s valuation.
- 🏭 Sector growth driven by innovation, exports, and demand in pharma and agrochemicals.
Conclusion
🔎 BASF is financially stable with low debt and strong global positioning but currently overvalued relative to peers. Entry should be considered near ₹3,000–₹3,200. Long-term holding is favorable only if earnings stabilize and valuation cools down.
Would you like me to extend this with a peer comparison or a intrinsic value analysis to refine the investment outlook?